262 related articles for article (PubMed ID: 18333373)
1. Platelet activation in patients with systemic scleroderma--pattern and significance.
Agache I; Rădoi M; Duca L
Rom J Intern Med; 2007; 45(2):183-91. PubMed ID: 18333373
[TBL] [Abstract][Full Text] [Related]
2. Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria.
Ferroni P; Guagnano MT; Falco A; Paoletti V; Manigrasso MR; Michetti N; Santilli F; Guadagni F; Basili S; Davì G
Clin Sci (Lond); 2008 Mar; 114(6):449-55. PubMed ID: 17988217
[TBL] [Abstract][Full Text] [Related]
3. Platelet P-selectin and GPIIb/IIIa expression after liver transplantation and resection.
Becker T; Jüttner B; Elsner HA; Meyer zu Vilsendorf A; Bornscheuer A; Nashan B; Brandl M; Klempnauer J; Piepenbrock S; Scheinichen D
Transpl Int; 2004 Sep; 17(8):442-8. PubMed ID: 15316595
[TBL] [Abstract][Full Text] [Related]
4. Platelet activation status decreases after menopause.
Aldrighi JM; Oliveira RL; D'Amico E; Rocha T; Gebara OE; Rosano GM; Ramires JA
Gynecol Endocrinol; 2005 May; 20(5):249-57. PubMed ID: 16019369
[TBL] [Abstract][Full Text] [Related]
5. Acetylsalicylic acid is compounding to antiplatelet effect of C-reactive protein.
Boncler M; Luzak B; Rozalski M; Golanski J; Rychlik B; Watala C
Thromb Res; 2007; 119(2):209-16. PubMed ID: 16473396
[TBL] [Abstract][Full Text] [Related]
6. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
[TBL] [Abstract][Full Text] [Related]
7. Elevated platelet-monocyte complexes in patients with psoriatic arthritis.
Pamuk GE; Nuri Pamuk O; Orüm H; Arican O; Turgut B; Demir M
Platelets; 2009 Nov; 20(7):493-7. PubMed ID: 19852688
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of high-sensitivity C-reactive protein and soluble markers of vascular endothelial cell activation in growth hormone-deficient adolescents.
Lanes R; Marcano H; Villaroel O; Gunczler P; Morillo E; Paoli M; Perez M; Maulino N; Palacios A
Horm Res; 2008; 70(4):230-5. PubMed ID: 18772596
[TBL] [Abstract][Full Text] [Related]
9. Relationship between soluble P-selectin and inflammatory factors (interleukin-6 and C-reactive protein) in colorectal cancer.
Dymicka-Piekarska V; Matowicka-Karna J; Gryko M; Kemona-Chetnik I; Kemona H
Thromb Res; 2007; 120(4):585-90. PubMed ID: 17169411
[TBL] [Abstract][Full Text] [Related]
10. Enhanced platelet responsiveness due to chilling and its relation to CD40 ligand level and platelet-leukocyte aggregate formation.
Ayukawa O; Nakamura K; Kariyazono H; Ikeda R; Arima J; Shinkawa T; Iwase H; Sakata R; Yamada K
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):176-84. PubMed ID: 19300046
[TBL] [Abstract][Full Text] [Related]
11. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
Chung I; Choudhury A; Patel J; Lip GY
Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
[TBL] [Abstract][Full Text] [Related]
12. Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin.
Undas A; Stepień E; Branicka A; Wołkow P; Zmudka K; Tracz W
Kardiol Pol; 2009 Jun; 67(6):591-8. PubMed ID: 19618315
[TBL] [Abstract][Full Text] [Related]
13. Platelet activation, endothelial cell dysfunction in the absence of anticardiolipin antibodies in systemic sclerosis.
Lima J; Fonollosa V; Fernández-Cortijo J; Ordi J; Cuenca R; Khamashta MA; Vilardell M; Simeón CP; Picó M
J Rheumatol; 1991 Dec; 18(12):1833-6. PubMed ID: 1839040
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of platelet GPIIb-IIIa and P-selectin expression by aspirin is impaired by stress hyperglycemia.
Le Guyader A; Pacheco G; Seaver N; Davis-Gorman G; Copeland J; McDonagh PF
J Diabetes Complications; 2009; 23(1):65-70. PubMed ID: 18413191
[TBL] [Abstract][Full Text] [Related]
15. Levels of F2-isoprostanes in systemic sclerosis: correlation with clinical features.
Volpe A; Biasi D; Caramaschi P; Mantovani W; Bambara LM; Canestrini S; Ferrari M; Poli G; Degan M; Carletto A; Pieropan S; Minuz P
Rheumatology (Oxford); 2006 Mar; 45(3):314-20. PubMed ID: 16219641
[TBL] [Abstract][Full Text] [Related]
16. Platelet activation in patients with peripheral vascular disease: reproducibility and comparability of platelet markers.
Burdess A; Michelsen AE; Brosstad F; Fox KA; Newby DE; Nimmo AF
Thromb Res; 2012 Jan; 129(1):50-5. PubMed ID: 21937092
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers.
Allanore Y; Borderie D; Meune C; Lemaréchal H; Weber S; Ekindjian OG; Kahan A
Ann Rheum Dis; 2005 Mar; 64(3):481-3. PubMed ID: 15708899
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: a link to protection against atherosclerosis?
Tapan S; Dogru T; Tasci I; Ercin CN; Ozgurtas T; Erbil MK
Clin Biochem; 2009 Jun; 42(9):791-5. PubMed ID: 19232335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
